Pharmaceutical company Galderma is discontinuing the Restylane Fynesse dermal filler from the Optimal Balance Technology (OBT) range.
The company explains that the Fynesse product will be replaced within the portfolio by Restylane Refyne, a dermal filler able to treat more areas as opposed to Fynesse which was primarily indicated for the correction of fine lines.
The Refyne filler can be used for treating moderate wrinkles and address prominent areas of concern such as the nasolabial folds and marionette lines, explains Galderma.
The Restylane OBT
range will now include four key products: Refyne, Kysse, Defyne and Volyme.
